Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/124482
Title: Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency
Author: Lovric, Svjetlana
Goncalves, Sara
Gee, Heon Yungy
Oskouian, Babak
Srinivas, Honnappa
Choi, Won-Il
Shril, Shirlee
Ashraf, Shazia
Tan, Weizhen
Rao, Jia
Airik, Merlin
Schapiro, David
Braun, Daniela A.
Sadowski, Carolin E.
Widmeier, Eugen
Jobst-Schwan, Tilman
Schmidt, Johanna Magdalena
Girik, Vladimir
Capitani, Guido
Suh, Jung H.
Lachaussée, Noëlle
Arrondel, Christelle
Patat, Julie
Gribouval, Olivier
Furlano, Monica
Boyer, Olivia
Schmitt, Alain
Vuiblet, Vincent
Hashmi, Seema
Wilcken, Rainer
Bernier, Francois P.
Innes, A. Micheil
Parboosingh, Jillian S.
Lamont, Ryan E.
Midgley, Julian P.
Wright, Nicola
Majewski, Jacek
Zenker, Martin
Schaefer, Franz
Kuss, Navina
Greil, Johann
Giese, Thomas
Schwarz, Klaus
Catheline, Vilain
Schanze, Denny
Franke, Ingolf
Sznajer, Yves
Truant, Anne S.
Adams, Brigitte
Desir, Julie
Biemann, Ronald
Pei, York
Ars, Elisabet
Lloberas Blanch, Núria
Madrid, Alvaro
Dharnidharka, Vikas R.
Connolly, Anne M.
Willing, Marcia C.
Cooper, Megan A.
Lifton, Richard P
Simons, Matias
Riezman, Howard
Antignac, Corinne
Saba, Julie D.
Hildebrandt, Friedhelm
Keywords: Síndrome nefròtica
Insuficiència renal crònica
Nephrotic syndrome
Chronic renal failure
Issue Date: 1-Mar-2017
Publisher: American Society for Clinical Investigation
Abstract: Steroid-resistant nephrotic syndrome (SRNS) causes 15% of chronic kidney disease cases. A mutation in 1 of over 40 monogenic genes can be detected in approximately 30% of individuals with SRNS whose symptoms manifest before 25 years of age. However, in many patients, the genetic etiology remains unknown. Here, we have performed whole exome sequencing to identify recessive causes of SRNS. In 7 families with SRNS and facultative ichthyosis, adrenal insufficiency, immunodeficiency, and neurological defects, we identified 9 different recessive mutations in SGPL1, which encodes sphingosine-1-phosphate (S1P) lyase. All mutations resulted in reduced or absent SGPL1 protein and/or enzyme activity. Overexpression of cDNA representing SGPL1 mutations resulted in subcellular mislocalization of SGPL1. Furthermore, expression of WT human SGPL1 rescued growth of SGPL1-deficient dpl1. yeast strains, whereas expression of disease-associated variants did not. Immunofluorescence revealed SGPL1 expression in mouse podocytes and mesangial cells. Knockdown of Sgpl1 in rat mesangial cells inhibited cell migration, which was partially rescued by VPC23109, an S1P receptor antagonist. In Drosophila, Sply mutants, which lack SGPL1, displayed a phenotype reminiscent of nephrotic syndrome in nephrocytes. WT Sply, but not the disease-associated variants, rescued this phenotype. Together, these results indicate that SGPL1 mutations cause a syndromic form of SRNS.
Note: Reproducció del document publicat a: https://doi.org/10.1172/JCI89626
It is part of: Journal of Clinical Investigation, 2017, vol. 127, num. 3, p. 912-928
URI: http://hdl.handle.net/2445/124482
Related resource: https://doi.org/10.1172/JCI89626
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Publicacions de projectes de recerca finançats per la UE

Files in This Item:
File Description SizeFormat 
LovricS.pdf6.41 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.